Physician profile
Wafic Itani
NPI 1700306024
$5,313.86
in general payments reported to CMS, 2019-2025
16 companies · $1,542 in 2025
The $1,542 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $326 · 2022: $226 · 2023: $1,104 · 2024: $2,017 · 2025: $1,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,580 · Education: $82.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,579.61 |
| Education | $82.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,569.04 | 2021-2025 | Farxiga, Lokelma, Wainua |
| Abbott Laboratories | $724.90 | 2023-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $654.15 | 2023-2025 | Watchman Access System, General - Therapies |
| E.R. Squibb & Sons, L.L.C. | $524.63 | 2022-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $491.18 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $374.61 | 2024-2025 | Lifevest |
| Heartflow, INC. | $177.54 | 2025 | |
| Medtronic, INC. | $168.68 | 2023 | Linq II |
| Pfizer INC. | $161.60 | 2024 | |
| Bridgebio Pharma, INC. | $158.07 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $121.13 | 2024 | Evkeeza |
| Genentech USA, INC. | $99.99 | 2019 | |
| Scpharmaceuticals INC. | $31.51 | 2025 | |
| Merck Sharp & Dohme LLC | $28.68 | 2024 | Verquvo |
| Amgen INC. | $15.43 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wafic Itani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.